Streetbeat News

Products Services

IBRX

ImmunityBio, Inc. (IBRX) has completed the drug substance for ANKTIVA, sufficient for 170,000 doses, and announced its GMP fill-finish facility in New York is on track for completion in 12-18 months. This progress, along with a partnership with the Serum Institute of India for BCG availability, positions ImmunityBio for the commercial launch and clinical trials of ANKTIVA. Significant investments have been made in facilities for global capacity, with a California manufacturing plant also nearing completion to support large-scale production.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:19 pm

CRWD

CrowdStrike (NASDAQ:CRWD) and NinjaOne announced a strategic partnership to offer comprehensive endpoint protection against cyberattacks by integrating NinjaOne's endpoint management with CrowdStrike's Falcon XDR platform. This collaboration aims to enhance detection, investigation, and response to attacks, leveraging AI to reduce response times by up to 95%. The partnership addresses the challenges of a hybrid workforce and the surge in endpoint devices, aiming to simplify security and management for IT and security teams.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:17 pm

ODII

POWI

Power Integrations (NASDAQ:POWI) has announced an agreement to acquire the assets of Odyssey Semiconductor Technologies (OTCQB:ODII), a developer of vertical gallium-nitride (GaN) transistor technology. This acquisition is aimed at enhancing Power Integrations' development of high-voltage, high-power GaN technology, supporting its PowiGaN technology roadmap. The transaction is expected to close in July 2024, with key Odyssey employees joining Power Integrations. This move is part of Power Integrations' strategy to achieve cost parity with silicon MOSFETs and expand the voltage and power capabilities of its GaN technology.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:16 pm

PANW

Palo Alto Networks (NASDAQ:PANW) has launched new AI-powered security solutions, including AI Access Security, AI Security Posture Management (AI-SPM), and AI Runtime Security, leveraging its proprietary Precision AI technology. These solutions aim to protect against AI-generated threats and secure AI adoption by combining machine learning, deep learning, and generative AI. The offerings are integrated across Palo Alto Networks' platforms (Strata, Prisma, and Cortex) and include advanced security services to counter web-based threats, zero-day threats, and more, while also ensuring the secure development and deployment of AI applications.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:16 pm

SYNX

Silynxcom Ltd. (NYSE:SYNX) and 3M PELTOR have expanded their collaboration to include the new Peltor ComTac VIII Headset, enhancing their range of tactical communication solutions. The ComTac VIII offers improved sound protection and situational awareness, marking a significant advancement in headset technology for tactical environments.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:15 pm

AMZN

VCR

XLY

Amazon.com Inc (NASDAQ:AMZN) has launched its online shopping service, Amazon.co.za, in South Africa, offering a wide range of local and international brands across 20 product categories. The service features same-day and next-day delivery options, free shipping on initial orders and orders above 500 rand, and hassle-free returns. This move is part of Amazon's strategy to tap into the growing online shopping market in South Africa, a key entry point into the African market. Amazon stock has seen significant growth, and exposure to AMZN can be gained through ETFs like the Consumer Discretionary Select Sector SPDR Fund (NYSE:XLY) and the Vanguard Consumer Discretionary ETF (NYSE:VCR).

Portfolio Pulse from Shivani Kumaresan

May 07, 2024 | 12:14 pm

ARDX

Ardelyx, Inc. (NASDAQ:ARDX) announced it will present additional data on IBSRELA (tenapanor) for treating irritable bowel syndrome with constipation (IBS-C) at the 2024 Digestive Disease Week Conference. The data includes posthoc analyses from Phase 3 studies and a product theater discussing IBSRELA's mechanism and clinical trial efficacy and safety data.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:13 pm

GOOG

ZS

Zscaler, Inc. (NASDAQ:ZS) has announced a collaboration with Google to integrate Zscaler Private Access with Chrome Enterprise, creating a joint zero trust architecture. This partnership aims to enhance cybersecurity by providing secure access to private applications and advanced threat and data protection. The collaboration leverages the strengths of both companies to offer a solution that minimizes attack surfaces, simplifies management, and improves user experience while promoting flexibility and productivity. The initiative is expected to replace legacy VPNs and firewalls, offering a more secure and efficient way to access corporate resources.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:12 pm

ALIM

Alimera Sciences, Inc. (NASDAQ:ALIM) announced its participation in upcoming ophthalmic conferences with three scientific abstracts highlighting the effectiveness of YUTIQ, a fluocinolone acetonide intravitreal implant for treating chronic non-infectious uveitis. The presentations at the ARVO and RWC conferences will cover safety, retinal thickness outcomes, and long-term treatment benefits of YUTIQ, showcasing its CONTINUOUS MICRODOSING technology.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:11 pm

AWH

Aspira Women's Health Inc. (NASDAQ:AWH) announced the publication of two peer-reviewed manuscripts supporting the use of its OvaWatch diagnostic tool for ovarian cancer risk assessment in women with adnexal masses. The studies, published in Frontiers of Medicine and Gynecologic Oncology, demonstrate OvaWatch's potential to reduce unnecessary surgeries and provide effective risk monitoring, potentially accelerating its adoption for patient management. The company's total addressable market for its ovarian cancer risk assessment tests, OvaSuite, is estimated at 2.0-3.0 million tests per year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:10 pm